Regeneron Pharmaceuticals Revenue, Growth & Competitor Profile

Company Profile & Annual Report for Regeneron Pharmaceuticals

Access the complete profile.

Regeneron Pharmaceuticals Fast Facts

Revenue	Over $500 million    See Exact Annual Revenue
Employees	Over 1,000Exact Company Size
Primary Industry	325411 Medicinal & Botanical Manufacturing
Additional NAICS Codes	325412 Pharmaceutical Preparation Manufacturing
Address	777 Old Saw Mill River Road Tarrytown, NY 10591

Regeneron Pharmaceuticals's Annual Report & Profile shows critical firmographic facts:

• What is the company's size? (Annual sales and employees)
  • Regeneron Pharmaceuticals's annual revenues are Over $500 million (see exact revenue data)
• What industry is the company in?
  • Regeneron Pharmaceuticals is classified as operating in the Medicinal & Botanical Manufacturing industry, NAICS Code 325411.

Regeneron Pharmaceuticals is a publicly traded company on NMS using the ticker symbol REGN. Detailed information on company financials and operating reports can be found here: NMS: REGN

Regeneron Pharmaceuticals Annual Revenue and Growth Rate

Regeneron Pharmaceuticals	Revenue Est. ($ Million)	Growth Rate (%)	# Employees
2023	Over $500 million Details in Premium Report
2022
2021
2020
2019

1-Year Growth Rate: 3-Year Growth Rate (CAGR):

Note: Regeneron Pharmaceuticals's revenues are gauged from an analysis of company filings.

Trademark Applications

Trademark applications show the products and services that Regeneron Pharmaceuticals is developing and marketing. Regeneron Pharmaceuticals's new tradmarks suggest it is investing in R&D and marketing, while expanding into new products or markets. Trademarks may include brand names, product names, logos and slogans.

Trademark	Date
ORDSPONO SURROUND Financial administration services, namely, financial administration of a program to provide access to medicines at low or no cost to underserved populations; Financial administration services, namely, financial administration of a program to provide discounts on prescription medicines	11/02/2023
OZPAV Pharmaceutical preparations for the treatment of hematological, gastrointestinal, neuromuscular, muscular, cardiovascular, metabolic, immunological, inflammatory, oncological, ophthalmological, neurological, musculoskeletal, bone, connective tissue, dermatological, infectious, autoimmune, nephrological, hepatological, allergic, genetic, respiratory, viral diseases and disorders, and for the treatment of pain	03/16/2023
YUVARYC Pharmaceutical preparations for the treatment of hematological, gastrointestinal, neuromuscular, muscular, cardiovascular, metabolic, immunological, inflammatory, oncological, ophthalmological, neurological, musculoskeletal, bone, connective tissue, dermatological, infectious, autoimmune, nephrological, hepatological, allergic, genetic, respiratory, viral diseases and disorders, and for the treatment of pain	03/16/2023

See all trademarks and details in the Full Report.

Market Share of Regeneron Pharmaceuticals's Largest Competitors

A competitive analysis shows these companies are in the same general field as Regeneron Pharmaceuticals, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company	Headquarters	Revenue ($ MM)
XYMOGEN	Orlando, FL	100
AVANTI NUTRITIONAL LABORATORIES	Miami Lakes, FL	37
NUTRITION FORMULATORS	Miramar, FL	36
RTPR	Cabot, AR	33
INTEGRATED BOTANICS	Fort Worth, TX	29
COSMAX NBT USA	Garland, TX	29
CJB INDUSTRIES	Valdosta, GA	28
ALTERNATIVE LABORATORIES	Naples, FL	28
S&B PHARMA	Azusa, CA	28

Nearby Competitors

These companies are similar in business line and location to Regeneron Pharmaceuticals. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company	Headquarters	Revenue ($ MM)
REGENERON PHARMACEUTICALS	Tarrytown, NY	100
FUJIFILM DIOSYNTH BIOTECHNOLOGIES U.S.A.	Valhalla, NY	20
WELEDA	Irvington, NY	0
FUJIFILM WAKO DIAGNOSTICS U.S.A.	Valhalla, NY	0
ARMONK PHYSICAL THERAPY & SP	Armonk, NY	0
ARAIM PHARMACEUTICALS	Tarrytown, NY	0

Future Competition: Regeneron Pharmaceuticals's Fastest Growing Competitors

These companies are in the same general field as Regeneron Pharmaceuticals and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

Company	Revenue ($ MM)